BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11532042)

  • 21. Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.
    Gabalec F; Beranek M; Netuka D; Masopust V; Nahlovsky J; Cesak T; Marek J; Cap J
    Pituitary; 2012 Jun; 15(2):222-6. PubMed ID: 21597974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current pathological classification of pituitary adenomas.
    Saeger W
    Acta Neurochir Suppl; 1996; 65():1-3. PubMed ID: 8738481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical demonstration of tenascin in human pituitary glands and adenomas.
    Ikeda H; Yoshimoto T; Fujiwara K; Ogawa Y
    Acta Histochem; 1995 Jul; 97(3):273-80. PubMed ID: 8525784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Apparent contradictory findings in the immunohistochemical detection of hormone production in hypophyseal adenoma].
    Walter GF
    Acta Histochem Suppl; 1992; 42():225-30. PubMed ID: 1584969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical characterisation of human pituitary adenomas.
    Dorn A; Nyström S; Müller M; Rinne A; Kyllönen A; Bernstein HG; Schwesinger G; Leppäluoto J
    Zentralbl Neurochir; 1985; 46(3):188-94. PubMed ID: 3911665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenomas: clinicopathological and immunohistochemical study.
    Martinez AJ; Lee A; Moossy J; Maroon JC
    Ann Neurol; 1980 Jan; 7(1):24-36. PubMed ID: 6244771
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.
    Mihajlović M; Pekić S; Doknić M; Stojanović M; Rašić D; Miljić D; Petakov M; Manojlović Gačić E
    Int J Surg Pathol; 2024 May; 32(3):470-477. PubMed ID: 37438981
    [No Abstract]   [Full Text] [Related]  

  • 29. The 2017 WHO classification of pituitary adenoma: overview and comments.
    Inoshita N; Nishioka H
    Brain Tumor Pathol; 2018 Apr; 35(2):51-56. PubMed ID: 29687298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [120 biopsies of pituitary adenomas studied by immunohistochemistry and electron microscopy. A clinico-pathological correlation].
    Félix IA; Rodríguez Mendoza L; Guinto G; Torres Corzo J; Wussterhaus CA
    Gac Med Mex; 1992; 128(3):289-95. PubMed ID: 1302734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
    J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-subunit immunoreactivity in plurihormonal pituitary adenomas of patients with acromegaly.
    Kontogeorgos G; Kovacs K; Scheithauer BW; Rologis D; Orphanidis G
    Mod Pathol; 1991 Mar; 4(2):191-5. PubMed ID: 1646455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD markers in pituitary adenomas.
    Saeger W
    Endocr Pathol; 2001; 12(3):307-13. PubMed ID: 11740052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic Characteristics and Surgical Treatment of Plurihormonal Pituitary Adenomas.
    Aydin S; Comunoglu N; Ahmedov ML; Korkmaz OP; Oz B; Kadioglu P; Gazioglu N; Tanriover N
    World Neurosurg; 2019 Oct; 130():e765-e774. PubMed ID: 31295602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plurihormonal gonadotroph cell pituitary adenoma: report of a unique case.
    Al-Shraim M; Scheithauer BW; Horvath E; Kovacs K; Smyth H; Coire C; Lloyd RV; Jastania R; Al-Gahtany M
    Clin Neuropathol; 2009; 28(3):182-7. PubMed ID: 19537135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pituitary gland tumors].
    Saeger W
    Pathologe; 2003 Jul; 24(4):255-64. PubMed ID: 14513271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.
    Pawlikowski M
    Folia Histochem Cytobiol; 2010 Sep; 48(3):394-7. PubMed ID: 21071344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.